CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: domperidone
Accession: CHEBI:31515
browse the term
Definition: 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Synonyms: exact_synonym: 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
related_synonym: 5-chloro-1-(1-(3-(2-oxo-1-benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one; Formula=C22H24ClN5O2; InChI=1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30); InChIKey=FGXWKSZFVQUSTL-UHFFFAOYSA-N; SMILES=Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1; domperidona; domperidonum
alt_id: CHEBI:464745
xref: Beilstein:903774; CAS:57808-66-9; DrugBank:DB01184; Drug_Central:945; KEGG:D01745; LINCS:LSM-2850
xref_mesh: MESH:D004294
xref: Patent:DE2632870; Patent:US4066772
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects response to substance
ISO
ABCB1 gene SNP affects the susceptibility to Domperidone
CTD
PMID:21063774
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Adra1d
adrenoceptor alpha 1D
affects response to substance
ISO
ADRA1D gene SNP affects the susceptibility to Domperidone
CTD
PMID:21063774
NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:118,793,346...118,809,354
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
Domperidone inhibits the reaction [Indomethacin results in increased expression of CXCL2 mRNA]
CTD
PMID:21691039
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
Domperidone inhibits the reaction [Indomethacin results in increased expression of CXCL1 mRNA]
CTD
PMID:21691039
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Domperidone results in increased expression of CYP1A1 mRNA
CTD
PMID:9860486
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases hydroxylation
ISO
CYP1A2 protein results in increased hydroxylation of Domperidone
CTD
PMID:15327587
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases hydroxylation
ISO
CYP2B6 protein results in increased hydroxylation of Domperidone
CTD
PMID:15327587
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases hydroxylation
ISO
CYP2C8 protein results in increased hydroxylation of Domperidone
CTD
PMID:15327587
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases hydroxylation
ISO
CYP2D6 protein results in increased hydroxylation of Domperidone
CTD
PMID:15327587
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
CYP3A4 protein results in increased hydroxylation of and results in decreased alkylation of Domperidone
CTD
PMID:15327587
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Drd1
dopamine receptor D1
multiple interactions affects binding
ISO
Cyclosporine promotes the reaction [Domperidone binds to DRD1 protein]
CTD
PMID:12673668
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions affects binding
ISO EXP
Cyclosporine promotes the reaction [Domperidone binds to DRD2 protein] Domperidone binds to and results in decreased activity of DRD2 protein
CTD
PMID:2571179 PMID:8103596 PMID:10626749 PMID:12071432 PMID:12130853 PMID:12673668 More...
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Il6
interleukin 6
decreases expression
ISO
Domperidone results in decreased expression of IL6 protein
CTD
PMID:10568223
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity affects response to substance multiple interactions
ISO
Domperidone results in decreased activity of KCNH2 protein KCNH2 gene SNP affects the susceptibility to Domperidone Domperidone inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:15640612 PMID:19583963 PMID:21063774 PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Mpo
myeloperoxidase
multiple interactions
ISO
Domperidone inhibits the reaction [Indomethacin results in increased activity of MPO protein]
CTD
PMID:21691039
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Domperidone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]
CTD
PMID:21691039
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Prl
prolactin
multiple interactions increases expression
ISO EXP
Domperidone inhibits the reaction [Deoxyepinephrine results in decreased expression of PRL protein]; Domperidone inhibits the reaction [Dopamine results in decreased expression of PRL protein] Domperidone results in increased expression of PRL protein
CTD
PMID:1304515 PMID:1874184 PMID:6736848 PMID:8532072
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Domperidone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
G
Tgfb1
transforming growth factor, beta 1
decreases expression
ISO
Domperidone results in decreased expression of TGFB1 protein
CTD
PMID:10568223
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Domperidone binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:83,700,755...83,729,936
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all